Showing results (1371-1380 of 3,791) with videos related to

Sort By:
Pageof 380
Oncoimmunology|February 5, 2019
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidateEllen C Border, Joseph P Sanderson, Thomas Weissensteiner, et al.
Oncoimmunology|February 5, 2019
ISG20 promotes local tumor immunity and contributes to poor survival in human gliomaMengqi Gao, Yi Lin, Xing Liu, et al.
Oncoimmunology|February 5, 2019
Correction
Oncoimmunology|February 5, 2019
Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patientsHansol Lee, Camelia Quek, Ines Silva, et al.
Oncoimmunology|February 5, 2019
Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristicsShakila Jabeen, Jaime A Espinoza, Lilly Anne Torland, et al.
Oncoimmunology|February 5, 2019
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunityKathleen M Kokolus, Jeremy S Haley, Emily J Koubek, et al.
Oncoimmunology|February 5, 2019
Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapyJing Liu, Elisa A Rozeman, Jake S O'Donnell, et al.
Oncoimmunology|December 15, 2018
Systemic autophagy in the therapeutic response to anthracycline-based chemotherapyFrancesca Castoldi, Erika Vacchelli, Laurence Zitvogel, et al.
Oncoimmunology|December 15, 2018
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsMarion Dajon, Kristina Iribarren, Florent Petitprez, et al.
Oncoimmunology|December 15, 2018
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacyTiziana Triulzi, Luca Forte, Viola Regondi, et al.
Pageof 380